|
JP2013248327A
|
|
Medical laser irradiation device
|
|
JP2009040716A
|
|
Soft capsule film composition
|
|
JP2006056789A
|
|
Capsule film composition
|
|
JPH11349526A
|
|
New compound or its pharmacologically acceptable salt and antioxidant containing the same as active ingredient
|
|
JPH11332560A
|
|
Recombinant adenovirus, cosmid vector containing the recombinant virus genom and animal cell infected with the recombinant virus
|
|
JPH11187894A
|
|
Composition containing highly pure 9-cis-beta-carotene and its production
|
|
JPH11130670A
|
|
Osteoporosis therapeutic agent
|
|
JPH09248182A
|
|
Multilamellar liposome for embedding plasmid therein
|
|
JPH09136846A
|
|
Interferon gene embedding multilamellar liposome and therapy of malignant tumor using the same
|
|
JPH08268885A
|
|
Suppressing agent for increase of peroxylipid
|
|
JPH08119959A
|
|
Xhanthone derivative and inhibitor of monoamine oxidase containing the same as active ingredient
|
|
JPH05294991A
|
|
Production of 2-hydroxyestrogen 3-glycoside
|
|
JPH05294987A
|
|
Production of 2-benzyloxyestrogen compound
|
|
JPH05202092A
|
|
Production of 2-acetyloxy-3-oxy-substitutedestrogen
|
|
JPH05170790A
|
|
Production of catecholestrogen
|
|
JPH05170787A
|
|
Catecholestrogen glycoside and its used
|
|
JPH05170786A
|
|
Catecholestrogen glycoside and its used
|
|
JPH05178883A
|
|
Cyclodextrin clathrate complex of catechol estrogen and its use
|
|
JPH03115222A
|
|
Intravital lipoperoxide increase inhibiting agent
|
